G. Boudreau

Combined PD-L1 and TIM-3 blockade improves the expansion of fit human CD8+ antigen-specific T cells for adoptive immunotherapy

L. Busque, Vincent-Philippe Lavallée, A. Brasey, 2021, medRxiv.

Leukoreduction system chambers are a reliable cellular source for the manufacturing of T‐cell therapeutics

J. Delisle, S. Néron, C. Carli, 2018, Transfusion.

Combined PD-L1 and TIM3 blockade improves expansion of fit human CD8+ antigen-specific T cells for adoptive immunotherapy

Vincent-Philippe Lavallée, A. Brasey, J. Delisle, 2022, Molecular therapy. Methods & clinical development.